Estrogen receptor α (ERα)-positive breast cancers often find a way to circumvent endocrine therapies such as tamoxifen. A newly described ERα kinase, lemur tyrosine kinase-3 (LMTK3), may provide both a diagnostic advance and a new therapeutic target to fight these resistant, aggressive tumors.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation
Cell Death & Disease Open Access 25 May 2021
-
The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis
Nature Communications Open Access 22 August 2019
-
Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients
Breast Cancer Research and Treatment Open Access 04 January 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Marina Corral
References
Orlando, L. et al. Cancer Treat. Rev. 36 Suppl 3, S67–S71 (2010).
Ali, S. & Coombes, R.C. Nat. Rev. Cancer 2, 101–112 (2002).
Romano, A. et al. Mol. Cell. Endocrinol. 314, 90–100 (2010).
Osborne, C.K. et al. J. Natl. Cancer Inst. 95, 353–361 (2003).
Jordan, V.C. & O'Malley, B.W. J. Clin. Oncol. 25, 5815–5824 (2007).
Lonard, D.M., Tsai, S.Y. & O'Malley, B.W. Mol. Cell. Biol. 24, 14–24 (2004).
Zwart, W. et al. EMBO J. 26, 3534–3544 (2007).
Kato, S. et al. Science 270, 1491–1494 (1995).
Sarwar, N. et al. Endocr. Relat. Cancer 13, 851–861 (2006).
Giamas, G. et al. Nat. Med. 17, 715–719 (2011).
Guo, S. & Sonenshein, G.E. Mol. Cell. Biol. 24, 8681–8690 (2004).
Belguise, K. & Sonenshein, G.E. J. Clin. Invest. 117, 4009–4021 (2007).
Marsaud, V., Gougelet, A., Maillard, S. & Renoir, J.M. Mol. Endocrinol. 17, 2013–2027 (2003).
Xu, J., Wu, R.C. & O'Malley, B.W. Nat. Rev. Cancer 9, 615–630 (2009).
Hudis,, C.A. N. Engl. J. Med. 357, 39–51 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Johnson, A., O'Malley, B. ERasing breast cancer resistance through the kinome. Nat Med 17, 660–661 (2011). https://doi.org/10.1038/nm0611-660
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0611-660
This article is cited by
-
Computational discovery of novel human LMTK3 inhibitors by high throughput virtual screening using NCI database
Korean Journal of Chemical Engineering (2022)
-
OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation
Cell Death & Disease (2021)
-
The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis
Nature Communications (2019)
-
Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach
3 Biotech (2018)
-
Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients
Breast Cancer Research and Treatment (2013)
